Scott T Reents has sold ABBV and made no open-market buys since Mar 2023
EVP and CFO at AbbVie Inc.
SEC CIK 0001937048 · Filings on SEC.gov ↗
$0Bought
$4.9MSold
NoneLast buy
Every filing
2 filings since Mar 2023, newest first
Filings come from SEC EDGAR. Not investment advice.